Outcomes
- 01
oncology-pathological-complete-response-at-2-years-post-treatment-achieved-binary-measured
1 evidence row
- 02
oncology-psa-nadir-below-0-2-ng-per-milliliter-achieved-binary-measured
1 evidence row
- 03
safety-serious-adverse-events-count-cohort-measured
1 evidence row
- 04
survival-disease-free-proportion-cohort-measured
1 evidence row
- 05
survival-prostate-cancer-specific-disease-free-probability-cohort-measured
1 evidence row